crsp stock price guide
CRSP stock price (CRISPR Therapeutics AG)
crsp stock price is the market quotation for CRISPR Therapeutics AG, a Nasdaq‑listed biotechnology company. This article explains what the crsp stock price represents, where to find real‑time and delayed data, the company background that contextualizes price moves, major historical catalysts, common market statistics, how clinical and regulatory developments shape value, and practical steps to track CRSP in real time—including using Bitget's market tools and Bitget Wallet for custody.
As of 2026-01-25, according to Nasdaq, CRISPR Therapeutics AG is listed under the ticker CRSP on the Nasdaq exchange; market activity, live quotes, and official filings are available via the company investor relations and major market data providers.
Company overview
CRISPR Therapeutics AG is a clinical‑stage biotechnology company focused on developing gene‑editing therapies using CRISPR/Cas9 technology. Founded in the mid‑2010s and headquartered in Europe with major operations in the United States, the company advances therapeutics across hematology, oncology, and other genetic diseases through in‑house programs and collaborations. Understanding the crsp stock price begins with recognizing that the company’s valuation is tightly linked to clinical progress, regulatory milestones, and partner agreements rather than stable revenue streams typical of mature firms.
Ticker symbol and listing
- Primary ticker: CRSP
- Primary exchange: Nasdaq (trading currency: USD)
- Listing type: Common shares traded on Nasdaq under the CRSP ticker
When investors reference the crsp stock price, they are almost always referring to the market price of CRISPR Therapeutics AG shares quoted on Nasdaq in US dollars. Alternative listings or depositary receipts, if any, are secondary; the Nasdaq listing is the primary reference for most price feeds and analyst coverage.
Real‑time and delayed price data
When you check the crsp stock price, you may see either real‑time or delayed data depending on the source and access level.
- Intraday (real‑time) quotes: Provided by exchanges and paid data vendors. These show trade‑by‑trade prices and are updated continuously during market hours.
- Delayed quotes: Many free public sites and terminals show data delayed by a standard 15 minutes unless real‑time access is purchased.
Common price fields you will encounter when viewing the crsp stock price:
- Last price (most recent trade)
- Bid / Ask (current highest buy and lowest sell orders)
- Open, High, Low (for the current trading session)
- Previous close (last session’s settlement price)
- Volume and average daily volume
- 52‑week high / low
Major data providers and locations where the crsp stock price and related fields are typically displayed include the Nasdaq market activity page, major financial news sites, broker platforms, and charting services. For programmatic access, licensed market data APIs and broker APIs provide authenticated real‑time feeds.
Historical price performance
Historical performance helps frame how the crsp stock price has moved over time and which periods were most volatile. When analyzing historical returns consider common horizons: 1‑day, 1‑month, 1‑year, 5‑year, and intraday seasonality.
Key historical metrics to check when studying the crsp stock price:
- Period returns (1‑day, 1‑month, YTD, 1‑year, 5‑year)
- 52‑week high and low
- All‑time high / low
- Volatility measures over different windows (e.g., 30‑day historical volatility)
Note: biotech equities like CRSP can show large percentage swings around binary events (e.g., trial readouts). This means short‑term historical returns can be extreme compared with many non‑biotech stocks.
Notable historical price events
- IPO / initial public listing or key secondary offerings: listing events and major capital raises typically produce pronounced moves in the crsp stock price.
- Clinical trial readouts: positive or negative Phase 1/2/3 results for lead programs have historically produced sharp intraday moves.
- Regulatory decisions: approvals, complete response letters, or unexpected regulatory delays have caused large price gaps.
- Strategic partnerships and licensing deals: announcements of collaborations with larger pharmas or platform licensing can lift the crsp stock price.
- Earnings releases and financial updates: quarterly results and pipeline updates regularly influence investor expectations.
Each of these items has been a recurring driver of large percentage moves in the crsp stock price across the company’s history.
Key market statistics and metrics
Understanding the crsp stock price also requires familiarity with market statistics commonly reported alongside price data. Typical metrics include:
- Market capitalization: the total market value of outstanding shares derived from the crsp stock price multiplied by shares outstanding.
- Shares outstanding and free float: the number of shares used to compute market cap and available for trading.
- Average daily volume: indicates typical liquidity and how easily positions can be entered or exited without moving the crsp stock price materially.
- Beta: a measure of sensitivity to the broader market; biotech stocks often have elevated beta compared with large‑cap indices.
- Valuation ratios: price/earnings (P/E) may be negative or not meaningful for clinical‑stage firms lacking positive EPS; alternatives include price/sales or enterprise value metrics.
Where to find these metrics: company investor relations pages, exchange market pages like Nasdaq, and financial data providers. For the latest quantifiable stats on the crsp stock price and related market metrics, consult the company IR and primary market data sources.
Financial results and earnings impact
Quarterly and annual financial disclosures affect the crsp stock price primarily by updating investors on cash runway, R&D spending, revenue (if any), and operational guidance. For clinical‑stage companies, the market often places greater weight on pipeline milestones and cash position than on current revenue.
- Earnings release schedule: Typically published in the company’s investor relations calendar and via SEC filings.
- Filings to check: Form 10‑Q, 10‑K, 8‑K for material events; these filings can move the crsp stock price when they change expectations for program timelines or cash needs.
As a rule, unexpected changes to guidance, surprise expenses, or revisions to clinical timelines can affect the crsp stock price almost immediately after disclosure.
Drivers of price movement specific to biotech firms
Biotech company stock prices are driven by factors that differ from many other sectors. For the crsp stock price, the primary drivers are:
- Clinical trial outcomes: Trial success or failure for lead candidates often causes large, rapid price moves.
- Regulatory decisions: Approvals or denials from agencies or requests for additional data can shift valuation materially.
- Partnership and licensing deals: Commercial or development partnerships can de‑risk programs and push the crsp stock price higher.
- Intellectual property and patent news: Strengthening or weakening IP protection affects long‑term value.
- Financing events: Secondary offerings or convertible debt can cause dilution concerns that pressure the crsp stock price.
- Sector sentiment and risk appetite: Broader biotech investor risk tolerance, funding environment, and macro conditions influence volatility and multiple compression/expansion.
These drivers make the crsp stock price particularly sensitive to binary outcomes and news flow.
Analyst coverage and price targets
Sell‑side analysts publish reports that include ratings and price targets; these reports influence short‑ to medium‑term expectations for the crsp stock price.
- Consensus data: Aggregated analyst ratings and average price targets are available from financial data services.
- How analysts move the market: Upgrades or downgrades, and material changes to price targets, can change investor sentiment and affect the crsp stock price.
For the most current analyst consensus and target ranges, consult major data aggregators and the company’s IR summaries of coverage.
Trading instruments and derivatives
Investors and traders can access exposure to the crsp stock price through multiple instruments:
- Common shares: Direct ownership of CRSP common stock denominated in USD.
- Options: Listed options (calls and puts) may be available, allowing leveraged exposure or hedging related to the crsp stock price.
- Inclusion in ETFs and funds: Certain thematic or biotech ETFs may hold CRSP shares; ETF flows can indirectly affect the crsp stock price.
- Synthetic products: Some brokers offer CFDs or structured products tied to the crsp stock price; availability depends on jurisdiction and broker.
When trading any instrument tied to the crsp stock price, be mindful of liquidity, margin requirements, and product‑specific risks.
Risks and volatility considerations
Key risks tied to the crsp stock price include:
- Clinical and regulatory risk: Negative trial results or regulatory setbacks can quickly and severely reduce share value.
- Binary event risk: Single announcements (trial readouts, approval decisions) can lead to outsized moves.
- Dilution risk: Capital raises to fund development can dilute existing shareholders and impact the crsp stock price.
- Liquidity and trading risk: Lower average volume periods can create larger bid/ask spreads and more volatile intraday moves for the crsp stock price.
Investors and traders should account for these biotech‑specific risk profiles when assessing exposure to the crsp stock price.
How to track and access CRSP price data
Practical ways to monitor the crsp stock price:
- Company investor relations: The official source for corporate announcements and periodic filings that affect price.
- Exchange market pages: The Nasdaq market activity page for CRSP provides official session data and market metrics.
- Financial data providers and charting platforms: Used to view intraday charts, historical ranges, and watchlists for the crsp stock price.
- Broker platforms: For trading, research, and sometimes integrated news feeds—Bitget is recommended for traders seeking a platform that supports stock market access and related tools in jurisdictions where Bitget provides equities trading.
- Programmatic access: Licensed market data APIs and broker APIs provide feeds for the crsp stock price for algorithmic monitoring or automated alerts.
As of 2026-01-25, according to Nasdaq and company IR, the most authoritative sources of official CRSP market notices and filings are the Nasdaq quote feed and the company’s filings on the regulatory disclosure channels.
Historical charts and technical analysis
Charting the crsp stock price across multiple timeframes helps different user types:
- Intraday charts (1‑min to hourly): Useful for traders reacting to news that moves the crsp stock price within the session.
- Daily/weekly/monthly charts: Better for investors assessing trends and key support/resistance around the crsp stock price.
Common technical tools applied to the crsp stock price:
- Moving averages (SMA, EMA): To observe trend direction and dynamic support/resistance.
- RSI (Relative Strength Index): To identify potential overbought or oversold conditions for the crsp stock price.
- MACD: To spot momentum changes that may precede shifts in the crsp stock price.
Remember: technical analysis complements—rather than replaces—fundamental catalysts, which are particularly important for biotech names like CRSP.
Notable investors and institutional holdings
Institutional ownership and large investors can influence the crsp stock price through block trades, reported ownership changes, and proxy voting activity. Institutional holdings are disclosed in regulatory filings and aggregated on market data platforms. Monitoring 13F and similar holdings reports can provide insight into which funds and managers have exposure to CRSP and whether stakeholders are increasing or decreasing positions that may affect the crsp stock price.
Regulatory and reporting information
Official filings and regulatory announcements materially impact the crsp stock price. Relevant sources include:
- SEC filings (10‑Q, 10‑K, 8‑K) that disclose financial results, material events, and risk factors affecting the crsp stock price.
- Company investor relations releases and earnings calls, which often provide guidance and milestone updates tied to the crsp stock price.
- Exchange notices and corporate actions published by Nasdaq related to trading halts or corporate events.
For any material change affecting the crsp stock price, look for the corresponding SEC filing or company press release dated and timestamped for verification.
See also
- CRISPR Therapeutics company profile and investor relations
- Biotech investing basics and clinical trial phases
- Ticker lookup and market data resources
References
- Company investor relations pages and official filings for CRISPR Therapeutics AG (primary source for corporate disclosures affecting the crsp stock price).
- Nasdaq market activity page for CRSP (official exchange data and market notices as of the referenced date).
- Major financial data providers and charting platforms for price feeds and historical data used to analyze the crsp stock price.
As of 2026-01-25, according to Nasdaq and company IR reporting, the recommended authoritative sources for up‑to‑date, verifiable metrics related to the crsp stock price are the exchange feed and the company’s regulatory filings.
External links
- CRISPR Therapeutics investor relations and SEC filing pages (use these to confirm any material statements that could affect the crsp stock price).
- Nasdaq market pages and widely used financial platforms for live or delayed data on the crsp stock price.
Practical next steps: To monitor the crsp stock price in real time, set up alerts on your preferred charting platform, add CRSP to a watchlist on Bitget (where available), and enable email or app notifications for company press releases and SEC filings. For custody of digital‑asset related tools or Web3 integrations, consider Bitget Wallet when applicable.
Further exploration: review the company’s latest investor presentation and the most recent SEC filings before drawing conclusions about the crsp stock price movement. For ongoing market monitoring, use exchange feeds and licensed data APIs to ensure you receive timely updates.
